References

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

10.3322/caac.21660 · 2021 · External reference

Global burden of primary liver cancer in 2020 and predictions to 2040

10.1016/j.jhep.2022.08.021 · 2022 · External reference

The changing epidemiology of primary liver cancer

10.1007/s40471-019-00188-3 · 2019 · External reference

Epidemiology and Management of Hepatocellular Carcinoma

10.1053/j.gastro.2018.08.065 · 2019 · External reference

The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels

10.1002/cam4.4530 · 2022 · External reference

10.1038/s41572-020-00240-3

10.1038/s41572-020-00240-3 · 2021 · External reference

Unresolved reference

2016 · External reference

The Changing Global Epidemiology of Hepatocellular Carcinoma

10.1016/j.cld.2020.06.001 · 2020 · External reference

10.1186/s13643-021-01626-4

10.1186/s13643-021-01626-4 · 2021 · External reference

10.1186/1471-2288-14-135

10.1186/1471-2288-14-135 · 2014 · External reference

Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019

10.1002/cam4.4551 · 2022 · External reference

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

10.1053/j.gastro.2017.06.012 · 2017 · External reference

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

10.1038/s41575-020-00381-6 · 2021 · External reference

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

10.3201/eid2305.161477 · 2017 · External reference

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

10.1016/s2468-1253(18)30056-6 · 2018 · External reference

Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update

10.1016/s2468-1253(23)00321-7 · 2024 · External reference

Epidemiology of viral hepatitis and hepatocellular carcinoma

10.1053/j.gastro.2011.12.061 · 2012 · External reference

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

10.1016/j.jhep.2017.08.030 · 2017 · External reference

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

10.1016/s2468-1253(23)00335-7 · 2024 · External reference

Mechanisms of HBV-induced hepatocellular carcinoma

10.1016/j.jhep.2016.02.021 · 2016 · External reference

Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma

10.1016/j.jhep.2014.07.010 · 2014 · External reference

Management of hepatocellular carcinoma

10.1016/j.jhep.2018.03.019 · 2018 · External reference

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

10.1016/s2468-1253(21)00472-6 · 2022 · External reference

Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016

10.1001/jamanetworkopen.2018.6371 · 2018 · External reference

Screening and Treatment Program to Eliminate Hepatitis C in Egypt

10.1056/nejmsr1912628 · 2020 · External reference

Viral Interactions, Management, and Viral Reactivation

10.14218/jcth.2018.00016 · 2018 · External reference

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

10.1001/jama.2020.1123 · 2020 · External reference

World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma

10.1002/hep.27969 · 2015 · External reference

Unresolved reference

External reference

Ethics is not applicable because this study is based exclusively on published literature

External reference